Menopausal symptoms in older women and the effects of treatment with hormone therapy

Obstetrics and Gynecology

Volumn 100, Issue 6, 2002, Pages 1209-1218

  Barnabei, Vanessa M ^{a,b,c,d,e,f,g}   Grady, Deborah ^{a,b,c,d,e,f,g}   Stovall, Dale W ^{a,b,c,d,e,f,g}   Cauley, Jane A ^{a,b,c,d,e,f,g}   Lin, Feng ^{a,b,c,d,e,f,g}   Stuenkel, Cynthia A ^{a,b,c,d,e,f,g}   Stefanick, Marcia L ^{a,b,c,d,e,f,g}   Pickar, James H ^{a,b,c,d,e,f,g}  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY   (United States)

^g WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; FLUSHING; GENITAL TRACT INFECTION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SPOTTING; SYMPTOM; UTERUS BLEEDING; VAGINA DISCHARGE; VAGINAL DRYNESS; WAKEFULNESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; CONFIDENCE INTERVALS; EVALUATION STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036898842     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02369-4     Document Type: Article

References (17)

1. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol. 4:1977;31-47.
2. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
3. Grady D., Applegate W., Bush T., Furberg C., Riggs B., Hulley S.B. Heart and Estrogen/Progestin Replacement Study (HERS) Design, methods and baseline characteristics . Control Clin Trials. 19:1998;314-335.
4. Greene J.G. The cross-sectional legacy An introduction to longitudinal studies of the climacteric . Maturitas. 14:1992;95-101.
5. Neugarten B.L., Kraines R.J. "Menopausal symptoms" in women of various ages. Psychosom Med. 27:1965;266-273.
6. McKinlay S.M., Jefferys M. The menopausal syndrome. Br J Prev Soc Med. 28:1974;108-115.
7. Hunter M.S. Somatic experience of the menopause A prospective study . Psychosom Med. 52:1990;357-367.
8. Greendale G.A., Reboussin B.A., Hogan P., Barnabei V.M., Shumaker S., Johnson S., et al. Symptom relief and side effects of postmenopausal hormones Results from the Postmenopausal Estrogen/Progestin Interventions Trial . Obstet Gynecol. 92:1998;982-988.
9. Brown J.S., Grady D., Ouslander J.G., Herzog A.R., Varner R.E., Posner S.F. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol. 94:1999;66-70.
10. Linde MA. European survey of the perceived impact of urogenital ageing on quality of life. In: Barlow DH, ed. Towards a Better Recognition of Urogenital Ageing [Round Table Series No. 38]. London (UK): RSM Press, 1:15-20.
11. MacLennan A. Oral estrogen therapy versus placebo for hot flushes A systematic review . Climacteric. 4:2001;58-74.
12. Polo-Kantola P., Erkkola R., Helenius H., Irjala K., Polo O. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol. 178:1998;1002-1009.
13. Archer D.F., Pickar J.H., Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol. 83:1994;686-692.
14. Mattsson L.A., Bohnet H.G., Gredmark T., Torhorst J., Hornig F., Huls G. Continuous, combined hormone replacement Randomized comparison of transdermal and oral preparations . Obstet Gynecol. 94:1999;61-65.
15. Cano A., Tarin J.J., Duenas J.L. Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regime as postmenopausal hormone therapy. Fert Steril. 71:1999;129-136.
16. Greendale G.A., Reboussin B.A., Singh H.R., Olson L.K., Basset L.W., Wasilauskas C., et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Ann Intern Med. 130:1999;262-269.
17. Laya M.B., Gallagher J.C., Schreiman J.S., Larson E.B., Watson P., Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 196:1995;433-437.